Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 4534
118th Congress(2023-2024)
Women and Lung Cancer Research and Preventive Services Act of 2024
Active
Active
Passed House on Dec 16, 2024
Overview
Text
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
No Linkage Found
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 4534 (Reported-in-House)

Union Calendar No. 520

118th CONGRESS
2d Session
H. R. 4534

[Report No. 118–622]


To require a review of women and lung cancer, and for other purposes.

IN THE HOUSE OF REPRESENTATIVES

July 11, 2023

Mr. Boyle of Pennsylvania (for himself, Mr. Fitzpatrick, Ms. Blunt Rochester, Mr. Kilmer, Mr. Carbajal, and Mr. Raskin) introduced the following bill; which was referred to the Committee on Energy and Commerce

July 30, 2024

Additional sponsors: Ms. Pingree, Ms. Wasserman Schultz, Ms. Sewell, Ms. Houlahan, Ms. Moore of Wisconsin, Ms. Dean of Pennsylvania, Mr. Connolly, Ms. Clarke of New York, Ms. Wild, Mr. Rutherford, Mrs. Dingell, Ms. Kuster, Ms. Craig, Mrs. Trahan, Mr. David Scott of Georgia, Ms. Kelly of Illinois, Mr. Bacon, Ms. Stefanik, Mrs. González-Colón, Mr. Lawler, Ms. Castor of Florida, Mr. Ruiz, Mr. Cárdenas, Ms. Norton, Mr. Ciscomani, Mr. Evans, Mr. Doggett, Mrs. Fletcher, Mr. Van Drew, and Mr. Nunn of Iowa

July 30, 2024

Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed

[Strike out all after the enacting clause and insert the part printed in italic]

[For text of introduced bill, see copy of bill as introduced on July 11, 2023]

A BILL

To require a review of women and lung cancer, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Women and Lung Cancer Research and Preventive Services Act of 2024”.

SEC. 2. Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns.

(a) In general.—The Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities related to—

(1) research on lung cancer in women;

(2) research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force;

(3) access to lung cancer preventive services; and

(4) strategic public awareness and education campaigns on lung cancer.

(b) Content.—The review and recommendations under subsection (a) shall include—

(1) a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government;

(2) opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would—

(A) encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women;

(B) evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and

(C) foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities;

(3) opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and

(4) opportunities regarding the development of a national public education and awareness campaign on—

(A) lung cancer in women and underserved populations; and

(B) the importance of early detection of lung cancer.

(c) Report.—Not later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a).

Union Calendar No. 520

118th CONGRESS
     2d Session
H. R. 4534
[Report No. 118–622]
A BILL
To require a review of women and lung cancer, and for other purposes.
July 30, 2024
Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed